Semi‐automated thresholding technique for measuring lesion volumes in multiple sclerosis: effects of the change of the threshold on the computed lesion loads
暂无分享,去创建一个
G. Comi | M. Rovaris | M. Filippi | A. Campi | C. Pereira
[1] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[2] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[3] J. Olesen,et al. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.
[4] D. Li,et al. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features , 1989, Annals of neurology.
[5] V. Haughton,et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.
[6] A J Petkau,et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation , 1990, Neurology.
[7] R. Kikinis,et al. Three-dimensional segmentation of MR images of the head using probability and connectivity. , 1990, Journal of computer assisted tomography.
[8] A. Alavi,et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. , 1991, Radiology.
[9] D. Paty,et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation , 1991, Neurology.
[10] A. Alavi,et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. , 1991, Radiology.
[11] J. Friedman,et al. Quantitative MRI studies for assessment of multiple sclerosis , 1992, Magnetic resonance in medicine.
[12] R. Knobler,et al. Neuropsychological and structural brain lesions in multiple sclerosis , 1992, Neurology.
[13] The Use of Magnetic Resonance Imaging in Monitoring Interferon Therapy of Multiple Sclerosis , 1993, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[14] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[15] W. I. McDonald,et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.
[16] D. Li,et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis , 1994, Annals of neurology.
[17] P. Matthews,et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis , 1994, Annals of neurology.
[18] A. Fenster,et al. Computer‐assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain , 1994, Journal of magnetic resonance imaging : JMRI.
[19] D. Miller,et al. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.
[20] D. Miller,et al. Magnetic resonance in monitoring the treatment of multiple sclerosis , 1994, Annals of neurology.